Effect of an Inhaled .BETA.2-adrenergic Agent on Pulmonary Function and Quality of Life in Elderly Patients with Chronic Obstructive Pulmonary Disease.

Accession number;02A0372076
Title;Effect of an Inhaled .BETA.2-adrenergic Agent on Pulmonary Function and Quality of Life in Elderly Patients with Chronic Obstructive Pulmonary Disease.
Author; TERAMOTO SHINJI (Sannobyoin Kokyukinaika)
Journal Title;Japanese Journal of Geriatrics
Journal Code:Z0680A
ISSN:0300-9173
VOL.39;NO.2;PAGE.204-208(2002)
Figure&Table&Reference;FIG.1, TBL.5, REF.18
Pub. Country;Japan
Language;Japanese
Abstract;We tested the effects of inhaled .BETA.2-adrenergic drug on the physiologic function of the respiratory system and quality of life(QOL) in elderly patients with chronic obstructive pulmonary disease(COPD). We measured the pulmonary function, static respiratory pressures, and ventilation during exercise, before and after inhalation of the .BETA.2-adrenergic drug, fenoterol bromide(FB) in 12 male COPD patients(mean age 82.1.+-.0.6 years old). QOL was measured with a St George's Respiratory Questionnaire(SGRQ) in the patients. Forced expiratory volume in one second was increased by the inhalation of FB in the patients, whereas the ratio of residualvolume to total lung capacity was decreased by the inhalation. Maximum inspir atory pressure was significantly increased after the inhalation of FB. Dyspnea sensation during exercise assessed by the Borg scale was reduced by the inhalation of FB. The scores on SGRQ were improved by one-month treatment with FB. These results indicate that treatment with FB is effective for both physiological function of the respiratory system and several aspects of QOL in elderly patients with COPD. (author abst.)
FULLTEXT